Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Neutral M&G (MNG) by Citi
- Neutral Legal & General Group (LGEN) by Citi
- Neutral SSE (SSE) by Goldman Sachs
- Neutral National Grid (NG.) by Goldman Sachs
- Add Imperial Brands (IMB) by Simon Watkins in The Motley Fool
- Buy Essentra (ESNT) by Tom Winnifrith in ShareProphets
- Sell Wetherspoon (J.D.) (JDW) by Deutsche Bank
- Hold Melrose Industries (MRO) by Deutsche Bank
- Buy DFS Furniture (DFS) by Berenberg
- Add Standard Life plc (SDLF) by Simon Watkins in The Motley Fool
- Hold Lloyds Banking Group (LLOY) by Cliff D'Arcy in The Motley Fool
- Overweight Sabre Insurance Group (SBRE) by Barclays
- Equal Weight Lancashire Holdings Limited (LRE) by Barclays
- Overweight Hiscox Limited (DI) (HSX) by Barclays
- Buy Johnson Matthey (JMAT) by Berenberg
- Buy Croda International (CRDA) by Goldman Sachs
- Underperform Legal & General Group (LGEN) by RBC Capital
- Buy Oxford Biomedica (OXB) by Jefferies
- Buy Balfour Beatty (BBY) by Jefferies
- Sell KEFI Gold and Copper (KEFI) by Nigel Somerville in ShareProphets
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,440 open tips for GSK (GSK)
| Latest Bid : 1,943.00p | Latest Ask : 1,944.00p |
| High Today : 1,966.50p | Low Today : 1,906.28p |
| This Years High : 2,208.00p | This Years Low : 1,264.00p |
| Volume : 6,986,777 | MKT Cap : £80288.65M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Harvey Jones | Premium Only | 2025-02-07 08:00:00 07/02/2025 | 34.51% |
| Neutral | Goldman Sachs | Premium Only | 2025-02-07 06:44:00 07/02/2025 | – |
| Outperform | Bernstein | Premium Only | 2025-02-07 06:41:00 07/02/2025 | 34.51% |
| Underweight | JP Morgan | Premium Only | 2025-02-07 04:41:00 07/02/2025 | -0.94% |
| Hold | Deutsche Bank | Premium Only | 2025-02-06 07:17:00 06/02/2025 | -3.67% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Millennium International Management LP | 0.52% | 16/03/2026 |
| Latest Bid : 1,943.00p | Latest Ask : 1,944.00p |
| High Today : 1,966.50p | Low Today : 1,906.28p |
| This Years High : 2,208.00p | This Years Low : 1,264.00p |
| Volume : 6,986,777 | MKT Cap : £80288.65M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Harvey Jones | Premium Only | 2025-02-07 08:00:00 07/02/2025 | 34.51% |
| Neutral | Goldman Sachs | Premium Only | 2025-02-07 06:44:00 07/02/2025 | – |
| Outperform | Bernstein | Premium Only | 2025-02-07 06:41:00 07/02/2025 | 34.51% |
| Underweight | JP Morgan | Premium Only | 2025-02-07 04:41:00 07/02/2025 | -0.94% |
| Hold | Deutsche Bank | Premium Only | 2025-02-06 07:17:00 06/02/2025 | -3.67% |